European Cancer Congress Reinforcing multidisciplinarity

Transcription

1 ST REATI PO ST RT ICS 7th ECCO - 38th ESMO - 32nd ESTRO European Cancer Congress Reinforcing multidisciplinarity AMSTERDAM, 27 SEPTEMBER - OCTOBER 203 Contact In partnership: info@ecco-org.eu ECCO - the European CanCer Organisation Avenue E. Mounier 83 B-200 Brussels Belgium Tel:

2 ECC20/ECC203 comparisons Delegates attending ECCO6-ESMO36-ESTRO ECCO7-ESMO38-ESTRO % increase Submitted abstracts ECCO6-ESMO36-ESTRO ECCO7-ESMO38-ESTRO % increase App downloads ECCO6-ESMO36-ESTRO ECCO7-ESMO38-ESTRO % increase Tweets to official congress hashtag ECCO6-ESMO36-ESTRO ECCO7-ESMO38-ESTRO % increase 2

3 Registration and attendance Delegates (83.88%) 2 Exhibitors 62 (8.77%) 3 Invited Speakers 735 (4%) 4 Media 349 (.88%) 5 VIP and Guests 273 (.47%) Total participants % of total attendance 3

4 Figures from the scientific programme Abstracts Abstracts submitted Abstracts rejected 60 Oral Presentations 68 Poster Discussions 92 Poster Presentations Late Breaking Abstracts Late Breaking Abstracts submitted 26 Abstracts rejected 80 Oral in Presidential Session 4 Oral in Proffered Paper Session 29 Making a total of 39 sessions and over presentations 4

5 Top 0 countries USA (9.5%) The Netherlands (7.3%) 8 3 United Kingdom (7.2%) 4 France (7%) Germany (6.7%) 6 Switzerland (4.6%) 6 7 Italy (4.%) 8 Japan (3.5%) Spain (3.4%) 0 Belgium (3.%) % of total attendance Continent overview Europe (46%) Central & Eastern Europe (7.6%) 4 3 Americas (7%) 4 Asia (.5%) 5 Middle East (4.5%) 6 Africa (.5%) 3 7 Australasia (.%) 8 Other Countries (0.7%) 2 % of total attendance 5

6 Place of work Industry General Hospital University Hospital Cancer Centre Pharma Industry Other Cancer Research Centre Private Practice University Non-profit Organisation Government Contract Research Organisation Regulatory Authorities (20.2%) (7.9%) (5.2%) (4.7%) (8.6%) (8.3%) (4.3%) (3.7%) (3.2%) (.9%) (.%) (0.6%) (0.4%) % of total delegates 6

7 Specialisation in main tumour type Breast Other Colorectal Lung Prostate Blood Melanoma and Skin Ovarian Head and Neck Stomach Liver Kidney Pancreatic Brain Soft tissue Sarcoma Bladder Neuroendocrine Thyroid Cervix Bone Ocular (23,4%) (8,2%) (,8%) (8,4%) (5,2%) (4,0%) (3,3%) (3,0%) (2,9%) (2,8%) (2,7%) (2,6%) (2,3%) (2,%) (,5%) (,3%) (,3%) (,2%) (,%) (0,9%) (0,%) % of total delegates 7

8 Area of Main Interest Clinical Research Basic Science Drug Development Other Surgery Early Drug Development Systemic Therapy Radiotherapy Palliative Care Translational Research Geriatric Oncology Pathology Pharmacy Nursing Psychosocial Oncology Advocacy Oncology Pharmacy Paediatrics Policy Clinical Pharmacy Hospital Pharmacy (2,6%) (8,7%) (0,4%) (8,2%) (6,8%) (5,3%) (4,4%) (4,%) (2,7%) (2,6%) (2,4%) (2,3%) (2,3%) (2,%) (2,0%) (,%) (,%) (,0%) (0,7%) (0,%) (0,%) % of total delegates 8

9 Professions Medical Oncologist Industry Surgeon Basic and Translational Researchers Radiation Oncologist Nurse Clinical Oncologists Pharmacists Student Young Oncologist Haematologist Clinical Trial Coordinator General Practitioner Patient Advocate Paediatric Oncologist Gynaecologist Urologist Public Relations Imaging Specialist Statistician Pathologist Regulatory Investment Banker Society Administrator Business Analyst Neuro-Oncologist Public Affairs Policy Maker Neurologist Psychologist Palliative Care Specialist Geneticist Occupational Health Physiotherapist (3,%) (8,%) (0,0%) (7,2%) (5,5%) (4,8%) (4,%) (3,7%) (3,2%) (,7%) (,4%) (,3%) (,2%) (,%) (0,7%) (0,7%) (0,6%) (0,6%) (0,5%) (0,5%) (0,5%) (0,2%) (0,2%) (0,2%) (0,2%) (0,2%) (0,2%) (0,%) (0,%) (0,%) (0,%) (0,05%) (0,05%) (0,03%) % of total delegates 9

10 Media coverage by countries United States (63.74%) United Kingdom (8.22%) 3 Germany (5.66%) 4 Canada (4.8%) 4 5 France (3.54%) 3 6 Italy (.9%) 7 India (.69%) 2 8 United Arab Emirates (.43%) 9 Australia (.5%) 0 Spain (0.7%) Others (7.7%) Most covered stories from ECC 203 Worldwide media coverage gained included Zoran Gatalica: Identifying the disease-causing mechanisms in cancers with an unknown primary site improves treatment and survival Jean-Charles Soria: Promising results for new antibody drug in non-small cell lung cancer patients: smokers respond well Peter Boyle: The State of Oncology 203 new report draws attention to urgent need to tackle disparities in cancer care worldwide Stephen Hodi: Longest follow-up of largest number of melanoma patients treated with ipilimumab shows some survive up to ten years Felipe Ades: Survival after cancer diagnosis in Europe is strongly associated with how much governments spend on health care Mail on Sunday (UK) Bloomberg (news agency) Thomson Reuters (news agency) CBS News, El Mundo (Spain) Europa Press (Spanish news agency) Corriere della Sera (Italy) Le Figaro (France) Le Parisien (France) Medpage Today Medscape, NBC 2 News O Globo (Brazil) Daily Telegraph (UK) The Guardian (UK) The Wall Street Journal The Washington Post WebMD Westdeutscher Rudfunk (Germany) 0

11 The ECCO App, launched prior to ECC 203 Downloads to devices iphone 2 88 ipad 080 Android Total downloads (2 436 Downloads at ECC 20) Total user actions in the app: actions User activity per day in the app Sept 2 Sept 22 Sept 23 Sept 24 Sept 25 Sept 26 Sept 27 Sept 28 Sept 29 Sept 30 Sept Oct 2 Oct 3 Oct 203

12 0 most visited sessions in the app Presidential Session I: Best and Late Breaking Abstracts, Presidential Sessions views Gastrointestinal Malignancies - Colorectal Cancer I, Proffered Papers Session views Presidential Session II: Best and Late Breaking Abstracts, Presidential Sessions views Breast Cancer - Advanced Disease, Proffered Papers Session views Biological Basis of Personalised Cancer Therapy, Opening Session 3 47 views Gastrointestinal Malignancies - Colorectal Cancer II, Proffered Papers Session views Presidential Session III: Best and Late Breaking Abstracts, Presidential Sessions 3 64 views Lung Cancer - Metastatic, Proffered Papers Session 2 99 views Breast Cancer - Early Disease, Proffered Papers Session views Opening Ceremony, Opening Event views 2

13 Website traffic Visits to the ECC 203 Congress websites eccamsterdam203.ecco-org.eu 2.6 million pageviews during the entire lifetime of the congress site pageviews to the site during the congress days Session webcasts Over 000 webcasts available for delegates pageviews /day ECC 203 newsletters and eblasts leading up to congress Seven issues of Congress Update Service newsletters sent to over oncologists from over 20 countries Six eblasts on various Congress aspects (also distributed by 24 members societies, media partners etc.) 3

14 Social media At the European Cancer Congress, Twitter was used as the primary social networking platform. Here are the principal facts and figures. Twitter Tweets using official hashtag #ECC203: 740 tweets All those tweets had an outreach of 8 million impressions Individual users tweeting using #ECC203: 657 users Tweets per day using #ECC Oct 2 Oct Oct 30 Sept 29 Sept 28 Sept 27 Sept 26 Sept 25 Sept 24 Sept 203 4

15 5 most retweeted #ECC203 tweets Tweet Patient advocates across Europe object against Dutch regulation banning them from exhibit area at #ECC203 Mélanome avancé: une survie pouvant atteindre dix ans grâce à un médicament, l ipilimumab f24.my/63mxbk#afp #cancer #ECC203 #ECC203: Longest and largest trial of melanoma patients treated with ipilimumab shows survival up to ten years Approx. 40% of #cancer cases could be prevented by lifestyle changes. Learn more here bit.ly/otdpht #ECC203 #health Nederland is dit jaar gastland van #ECC203, het European Cancer Congress. De Koning is vanavond bij de officiële User Jan Brigitte 5 most favourited #ECC203 tweets Tweet Mélanome avancé: une survie pouvant atteindre dix ans grâce à un médicament, l ipilimumab f24.my/63mxbk#afp #cancer #ECC203 $BMY $MRK $RHHBY $AZN Anti-PD/PD-L Efficacy Summary Update after #ECC203 [JPM] Approx. 40% of #cancer cases could be prevented by lifestyle changes. Learn more here bit.ly/otdpht #ECC203 #health Ik Kleren ingepakt, pijnstillers, slaappillen, Ipad en visitekaartjes #ECC203. Op weg naar Amsterdam User Brigitte Andy 5

16 0 most influential accounts tweeting using #ECC203 Followers N of tweets Arts and Koninklijk Pfizer Teenage Cancer GE Matthew 6